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There is no ~roven~~era~y for vasodepressor vasovagal 
sywzope. This may be diagnosed by prolonged 60’ head-up 
tilt. Scopolamine (S) skin patches and B-blockers have 
been recommended, but only in open studies. Intravenous 
Clonidine (C) has blocked the vasodepressor reflex in 
carotid sinus syndrome. A randomised, double-blind, 
placebo-controlled, double-dummy, crossover trial of S, 
C and Atenolol (A) was undertaken. 16 patients were 
randomised, 6 male aged 62212 years. There were four 
six-week treatment periods with active treatment by one 
of the drugs and placebo (P) for the others with 
additional triple dummy phase. Daily symptom records 
were kept. In the fourth week of each period head-up 
tilt was repeated. Qcsurrence and timing of syncope were 
noted. 
RESULTS: 13 pat completed the study. 1 patient 
withdrew with side ts on P, 1 on S and 1 OR C. 
DRUG TILTS+VE TIME(MIN)+SD S!fNCOPE* 
s 13 6 33 +a h *during each 
C 13 37 +9 4 treatment period 
A 13 s” 19 +7 1 
P 13 9 26 +S 3 
There was no difference between the drugs in t 
number of positive kilts (Fisher's exact). The mean ei 
of syncope was not different between S and C, but both 
ared to P (pt0.03) mhd t0 A 
s also earlier with A than with P 
(PCO.02). 
CONCLUSION: This trial suggests benefit for C and S 
in vasodepressor vasovagal syncope. In view cP the 
number of syncopes reported with C, S is recommended as 
first line therapy. No role is found for therapy with 
A. 
